Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-13

FDA Approved: ATIVAN — Supplemental Application (Bausch Health US LLC)

View source ↗

Summary

The FDA approved a supplemental application for ATIVAN (lorazepam) submitted by Bausch Health US LLC. The action indicates a label update or related supplementa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ativan (Lorazepam)

Snippet

SUPPL AP for ATIVAN (LORAZEPAM)